Moomoo AI 已提取核心信息
AbbVie Inc. officer Timothy Richmond is set to sell 75,680 common shares of the company, with an aggregate market value of approximately $13.38 million, on March 1, 2024. The shares to be sold were recently acquired through stock option exercises and performance shares. Specifically, Richmond acquired 45,700 shares on March 1, 2024, through stock option exercise, paying with cash, and 29,980 shares on February 28, 2024, as performance shares from the issuer. There is no recent sale history reported for the past three months. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on November 13, 2023.
AbbVie Inc. officer Timothy Richmond is set to sell 75,680 common shares of the company, with an aggregate market value of approximately $13.38 million, on March 1, 2024. The shares to be sold were recently acquired through stock option exercises and performance shares. Specifically, Richmond acquired 45,700 shares on March 1, 2024, through stock option exercise, paying with cash, and 29,980 shares on February 28, 2024, as performance shares from the issuer. There is no recent sale history reported for the past three months. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on November 13, 2023.
艾伯维公司高管蒂莫西·里士满定于2024年3月1日出售该公司的75,680股普通股，总市值约为1,338万美元。拟出售的股票最近是通过股票期权行使和绩效股票收购的。具体而言，里士满于2024年3月1日通过行使股票期权以现金支付的方式收购了45,700股股票，并于2024年2月28日从发行人手中收购了29,980股作为业绩股。没有报告过去三个月的近期销售记录。计划出售的通知是在出售的同一天提交的，该交易的计划已于2023年11月13日通过。
艾伯维公司高管蒂莫西·里士满定于2024年3月1日出售该公司的75,680股普通股，总市值约为1,338万美元。拟出售的股票最近是通过股票期权行使和绩效股票收购的。具体而言，里士满于2024年3月1日通过行使股票期权以现金支付的方式收购了45,700股股票，并于2024年2月28日从发行人手中收购了29,980股作为业绩股。没有报告过去三个月的近期销售记录。计划出售的通知是在出售的同一天提交的，该交易的计划已于2023年11月13日通过。
有用
没用
